Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF)

Historical Holders from Q3 2021 to Q1 2025

Symbol
PROCF on OTC
Type / Class
Equity / Ordinary Shares, nominal value of $0.01 per share
Shares outstanding
2,461,355,158
All holders as of 31 Mar 2025
Q1 2025
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-5
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Hoche Partners Pharma Holding S.A. 84.38% $2,867,018,231 2,077,549,443 Hoche Partners Pharma Holding S.A. 16 Apr 2025
Flying Fish Ventures L.P. 84.38% $2,867,018,231 2,077,549,443 Flying Fish Ventures, L.P. 09 Apr 2025
Saint Thomas Commercial S.A. 84.38% $2,867,018,231 2,077,549,443 Saint Thomas Commercial S.A. 09 Apr 2025
Chemo Project, S.A. 53% $1,800,235,163 1,304,518,234 Chemo Project, S.A. 09 Apr 2025
Becaril S.A. 53% $1,800,235,163 1,304,518,234 Becaril S.A. 09 Apr 2025

Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q1 0 $0 -$1,613,042 0
2024 Q4 221,439 $1,613,042 +$1,242,140 $2.34 5
2024 Q3 166,189 $367,179 -$32,329 $2.2 5
2024 Q2 179,063 $452,581 +$209,627 $2.51 7
2024 Q1 89,855 $270,384 -$634,351 $2.9 9
2023 Q4 243,277 $990,304 +$226,732 $4.07 11
2023 Q3 62,661 $226,832 -$33,859 $3.62 8
2023 Q2 71,985 $342,514 -$629,823 $3.97 9
2023 Q1 220,633 $994,941 -$1,900,378 $4.51 6
2022 Q4 641,937 $3,369,033 -$2,182,064 $5.25 7
2022 Q3 1,067,698 $7,473,000 -$5,257,642 $7 8
2022 Q2 1,668,061 $15,545,000 -$1,097,988 $9.32 10
2022 Q1 1,795,515 $15,261,000 -$1,244,081 $8.5 9
2021 Q4 1,939,037 $18,861,000 -$318,530 $9.75 12
2021 Q3 1,941,513 $19,803,000 +$19,803,000 $10.2 15